Dermatologic inflammatory conditions require high loading and maintenance doses of biologic therapy-Reference-Cited by-同舟云学术

Dermatologic inflammatory conditions require high loading and maintenance doses of biologic therapy

Published:2022-07-04 Issue:10 Volume:36 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Greif C.¹²,Porter M.L.¹³^ORCID,Kimball A.B.¹³^ORCID

Affiliation:

1. Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology Beth Israel Deaconess Medical Center Boston Massachusetts USA

2. University of Texas Southwestern Medical School Dallas Texas USA

3. Department of Dermatology Beth Israel Deaconess Medical Center Boston Massachusetts USA

Funder

National Psoriasis Foundation

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.18268

Reference9 articles.

1. The pharmacological and clinical aspects behind dose loading of biological disease modifying anti-rheumatic drugs (bDMARDs) in auto-immune rheumatic diseases (AIRDs): rationale and systematic narrative review of clinical evidence

2. Secukinumab without the initial loading dose in the treatment of plaque‐type psoriasis – a simplified dosing regimen at the expense of efficacy?

3. A Retrospective Cohort Study Comparing Utilization and Costs of Biologic Therapies and JAK Inhibitor Therapy Across Four Common Inflammatory Indications in Adult US Managed Care Patients

4. Efficacy and safety of etanercept and adalimumab with and without a loading dose for psoriasis: A systematic review

5. Real‐world factors that affect the efficacy of biologics;Palmer WJ;Dermatol Times,2019